CRDF Q3'26 Earnings Preview Gives EPS Estimate of (0.14) USD
Cardiff Oncology is scheduled to report Q3'26 results on October 29; the release time is not specified. Revenue is estimated at 81.43 thousand USD, with EPS anticipated at (0.14) USD.
CRDF (Cardiff Oncology, Inc.) is set to announce its Q3'26 results on October 29, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 81.43 thousand USD with EPS (earnings per share) anticipated at (0.14) USD. Learn more details…